• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑人和白人住院患者中的抗抑郁药。对氯丙嗪和丙咪嗪对照试验的差异反应。

Antidepressants in black and white inpatients. Differential response to a controlled trial of chlorpromazine and imipramine.

作者信息

Raskin A, Crook T H

出版信息

Arch Gen Psychiatry. 1975 May;32(5):643-9. doi: 10.1001/archpsyc.1975.01760230109008.

DOI:10.1001/archpsyc.1975.01760230109008
PMID:1092283
Abstract

Differential effects of chlorpromazine, imipramine hydrochloride, and a placebo were examined in 159 black and 555 white depressed patients in a multihospital collaborative study. In making these comparisons, the effects of age and social class were controlled. The major study findings were the differential effects of the active drugs for the black men and women. Chlorpromazine was the most efficacious treatment for black women, whereas imipramine was most efficacious for black men. These differences occurred on global ratings of improvement as well as on specific symptoms such as depression, anxiety, guilt-worthlessness, sleep disturbances, and social participation. Black patients also evidenced a higher improvement rate at one week, irrespective of treatment, than did the white patients.

摘要

在一项多医院合作研究中,对159名黑人抑郁症患者和555名白人抑郁症患者,研究了氯丙嗪、盐酸丙咪嗪和安慰剂的不同疗效。在进行这些比较时,年龄和社会阶层的影响得到了控制。主要研究结果是活性药物对黑人男性和女性的不同疗效。氯丙嗪对黑人女性是最有效的治疗药物,而丙咪嗪对黑人男性最有效。这些差异体现在总体改善评分以及抑郁、焦虑、内疚感、睡眠障碍和社交参与等特定症状上。无论接受何种治疗,黑人患者在一周时的改善率也高于白人患者。

相似文献

1
Antidepressants in black and white inpatients. Differential response to a controlled trial of chlorpromazine and imipramine.黑人和白人住院患者中的抗抑郁药。对氯丙嗪和丙咪嗪对照试验的差异反应。
Arch Gen Psychiatry. 1975 May;32(5):643-9. doi: 10.1001/archpsyc.1975.01760230109008.
2
Chlorpromazine-chlordiazepoxide and chlorpromazine-imipramine treatment of newly hospitalized, acutely ill psychiatric patients.氯丙嗪-氯氮卓及氯丙嗪-丙咪嗪对新入院急性病精神病患者的治疗
Curr Ther Res Clin Exp. 1966 Mar;8(3):Suppl:117-52.
3
A guide for drug use in depressive disorders.
Am J Psychiatry. 1974 Feb;131(2):181-5. doi: 10.1176/ajp.131.2.181.
4
Differential response to chlorpromazine, imipramine, and placebo. A study of subgroups of hospitalized depressed patients.对氯丙嗪、丙咪嗪和安慰剂的差异反应。对住院抑郁症患者亚组的一项研究。
Arch Gen Psychiatry. 1970 Aug;23(2):164-73. doi: 10.1001/archpsyc.1970.01750020068009.
5
A comparative trial of imipramine and chlorpromazine in depressed patients.丙咪嗪与氯丙嗪治疗抑郁症患者的对比试验。
Br J Psychiatry. 1968 Oct;114(515):1281-7. doi: 10.1192/bjp.114.515.1281.
6
Prediction of drug effect by diagnostic decision tree.
Dis Nerv Syst. 1968 May;29(5):Suppl:159-87.
7
Importance of psychiatric diagnosis in prediction of clinical drug effects.
Arch Gen Psychiatry. 1967 Jan;16(1):118-26. doi: 10.1001/archpsyc.1967.01730190120016.
8
Prediction of psychopharmacologic effect in man: development and validation of a computerized diagnostic decision tree.人类精神药理效应的预测:计算机化诊断决策树的开发与验证
Comput Biomed Res. 1969 Jun;2(4):350-61. doi: 10.1016/0010-4809(69)90020-2.
9
The endogenous--neurotic distinction as a predictor of response to antidepressant drugs.内源性——神经症性区分作为抗抑郁药物反应的预测指标。
Psychol Med. 1976 Feb;6(1):59-70. doi: 10.1017/s0033291700007509.
10
Age-sex differences in response to antidepressant drugs.
J Nerv Ment Dis. 1974 Aug;159(2):120-30. doi: 10.1097/00005053-197408000-00006.

引用本文的文献

1
How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing?药物代谢和转运体遗传学如何为精神药物处方提供信息?
Front Genet. 2020 Dec 8;11:491895. doi: 10.3389/fgene.2020.491895. eCollection 2020.
2
Race, genetic ancestry and response to antidepressant treatment for major depression.种族、遗传背景与抗抑郁药治疗重度抑郁症的反应。
Neuropsychopharmacology. 2013 Dec;38(13):2598-606. doi: 10.1038/npp.2013.166. Epub 2013 Jul 5.
3
Biological variations in depression and anxiety between East and West.东西方抑郁症和焦虑症的生物学差异。
CNS Neurosci Ther. 2009 Fall;15(3):283-94. doi: 10.1111/j.1755-5949.2009.00093.x.
4
Ethnic differences in the risks of adverse reactions to drugs used in the treatment of psychoses and depression: a systematic review and meta-analysis.治疗精神病和抑郁症所用药物不良反应风险的种族差异:系统评价与荟萃分析
Drug Saf. 2008;31(7):597-607. doi: 10.2165/00002018-200831070-00005.
5
Duloxetine in the treatment of major depressive disorder: comparisons of safety and efficacy.度洛西汀治疗重度抑郁症:安全性与疗效比较
J Natl Med Assoc. 2006 Mar;98(3):437-47.
6
A comparison of antidepressant trials using active and inert placebos.使用活性安慰剂和惰性安慰剂的抗抑郁试验比较。
Int J Methods Psychiatr Res. 2003;12(3):117-27. doi: 10.1002/mpr.148.
7
Ethnic differences in the neuroleptic treatment of schizophrenia.精神分裂症抗精神病药物治疗中的种族差异。
Psychiatr Q. 1999 Summer;70(2):163-72. doi: 10.1023/a:1022153403924.
8
Black and white patients response to antidepressant treatment for major depression.
Psychiatr Q. 1998 Summer;69(2):117-25. doi: 10.1023/a:1024762503100.
9
Clinical trials and transethnic pharmacology.临床试验与跨种族药理学。
Drug Saf. 1994 Nov;11(5):378-91. doi: 10.2165/00002018-199411050-00005.